1. Home
  2. BXSL vs PTCT Comparison

BXSL vs PTCT Comparison

Compare BXSL & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Secured Lending Fund of Beneficial Interest

BXSL

Blackstone Secured Lending Fund of Beneficial Interest

HOLD

Current Price

$24.74

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$65.57

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXSL
PTCT
Founded
2018
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.7B
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
BXSL
PTCT
Price
$24.74
$65.57
Analyst Decision
Buy
Buy
Analyst Count
10
17
Target Price
$27.18
$80.65
AVG Volume (30 Days)
2.6M
977.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
12.87%
N/A
EPS Growth
N/A
264.48
EPS
2.46
7.78
Revenue
N/A
$264,734,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.70
P/E Ratio
$10.15
$8.37
Revenue Growth
N/A
36.19
52 Week Low
$22.47
$35.95
52 Week High
$32.81
$87.50

Technical Indicators

Market Signals
Indicator
BXSL
PTCT
Relative Strength Index (RSI) 57.02 41.79
Support Level $23.32 $62.72
Resistance Level $24.89 $69.23
Average True Range (ATR) 0.56 2.87
MACD 0.10 -0.74
Stochastic Oscillator 72.01 24.26

Price Performance

Historical Comparison
BXSL
PTCT

About BXSL Blackstone Secured Lending Fund of Beneficial Interest

Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: